TY  - JOUR
AU  - Zarzuelo Romero, María José
AU  - Pérez Ramírez, Cristina
AU  - Carrasco Campos, María Isabel
AU  - Sánchez Martín, Almudena
AU  - Calleja Hernández, Miguel Ángel
AU  - Ramírez Tortosa, María Carmen
AU  - Jiménez Morales, Alberto
PY  - 2021
DO  - 10.3390/jpm11050335
SN  - 2075-4426
UR  - http://hdl.handle.net/10668/17700
T2  - Journal of personalized medicine
AB  - The introduction of new therapies for the treatment of multiple sclerosis (MS) is a very recent phenomenon and little is known of their mechanism of action. Moreover, the response is subject to interindividual variability and may be affected by...
LA  - en
KW  - alemtuzumab
KW  - cladribine
KW  - dimethyl fumarate
KW  - fingolimod
KW  - multiple sclerosis
KW  - natalizumab
KW  - ocrelizumab
KW  - polymorphisms
KW  - response
KW  - siponimod
KW  - teriflunomide
TI  - Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis.
TY  - research article
VL  - 11
ER  -